[HTML][HTML] Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review

EC Arrúa, KP Seremeta, GR Bedogni, NB Okulik… - Acta tropica, 2019 - Elsevier
Neglected tropical diseases (NTDs) constitute a group of infectious diseases prevalent in
countries with tropical and subtropical climate that affect the poorest individuals and produce …

Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study

FQ Pires, T Angelo, JKR Silva, LCL Sá-Barreto… - … of pharmaceutical and …, 2017 - Elsevier
The objective of this work was to access thymol-excipient compatibility using an alternative
protocol of mixture design subsidizing the development of nanostructures lipid carriers …

Thermal behaviour studies of procaine and benzocaine: Part 1. Kinetic analysis of the active substances under non-isothermal conditions

A Fulias, G Vlase, C Grigorie, I Ledeţi, P Albu… - Journal of thermal …, 2013 - Springer
The analysed substances, procaine and benzocaine, are two anaesthetic agents currently
being administered in tablet form, also in the topical (cream, gel, balm) and injectable …

Mixture design applied in compatibility studies of catechin and lipid compounds

R Ferreira-Nunes, T Gratieri, GM Gelfuso… - … of pharmaceutical and …, 2018 - Elsevier
The aim of this work was to evaluate the compatibility of (+)-catechin (CA) and excipients
commonly used to prepare micro and nanoemulsions using thermal analysis along with …

Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based drug delivery systems

LAD Silva, FV Teixeira, RC Serpa, NL Esteves… - Journal of thermal …, 2016 - Springer
Carvedilol (CARV) is a widely used non-selective β-blocker, which has shown low
bioavailability after oral administration (20%) due to its low water solubility and intense first …

[HTML][HTML] Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies

G Muraca, ME Ruiz, RC Gambaro… - Beilstein Journal of …, 2023 - beilstein-journals.org
Chagas disease is a neglected endemic disease prevalent in Latin American countries,
affecting around 8 million people. The first-line treatment, benznidazole (BNZ), is effective in …

FTIR, Raman spectroscopy and HT-XRD in compatibility study between naproxen and excipients

B Rojek, M Gazda, A Plenis - Spectrochimica Acta Part A: Molecular and …, 2023 - Elsevier
Detection of incompatibility between an active pharmaceutical ingredient (API) and
excipients, including the selection of the most biopharmaceutical advantageous excipients is …

Preformulation studies of itraconazole associated with benznidazole and pharmaceutical excipients

I Alves-Silva, LCL Sá-Barreto, EM Lima… - Thermochimica …, 2014 - Elsevier
Recent studies have shown that the antifungal itraconazole (ITZ), when in associations with
benznidazole (BNZ), is a potential treatment for Chagas disease. Therefore, the objective of …

First solid-state NMR spectroscopy evaluation of complexes of benznidazole with cyclodextrin derivatives

J Priotti, MJG Ferreira, MC Lamas, D Leonardi… - Carbohydrate …, 2015 - Elsevier
Complexation of benznidazole (BZL), a drug of choice for the treatment of Chagas'
neglected disease, with cyclodextrin (CD) derivatives was analyzed by solid-state NMR. 13 …

Compatibility studies between an amphiphilic pH-sensitive polymer and hydrophobic drug using multiscale simulations

Y Wang, JW Ren, CY Zhang, MC He, ZM Wu, XD Guo - RSC advances, 2016 - pubs.rsc.org
The compatibility of an amphiphilic pH-sensitive polymer (docosahexaenoic acid–histidine–
lysine, DHA–HisXLys10) and hydrophobic drug (doxorubicin, DOX) was investigated using …